RHEACELL announces "First Patient In": EB-Haus in Salzburg, Austria starts pivotal study for stem cell therapy for severe forms of Epidermolysis bullosa that is longed for by those affected

Toronto, ON — Imagine telling a patient suffering from age-related (type-II) osteoporosis that a single injection of stem cells could restore their normal bone structure. This week, with a publication in STEM CELLS Translational Medicine, a group of researchers from the University of Toronto and The Ottawa Hospital suggest that this scenario may not be […]

Autolus Therapeutics’ Aucatzyl is now FDA approved for treating advanced cases of B-cell precursor acute lymphoblastic leukemia. While it goes after the same target as Gilead Sciences’ Tecartus, Autolus engineered its CAR T-therapy with properties that could improve safety, efficacy, and durability.

The post ‘Serial Killing’ Cell Therapy From Autolus Lands FDA Approval in Blood Cancer appeared first on MedCity News.

A newly developed platform mimics nature to enhance immune-based treatments in the fight against medlinkcancer/medlink. h2Fighting Cancer from

Autologous hematopoietic stem cell transplantation or aHSCT, often used to treat medlinkblood cancers/medlink, was also demonstrated to be safe and

Researchers in Australia have identified a previously unknown population of stem cells fibroblast growth factor 18 (FGF18) stimulated Gremlin 1 cells,

Stem cell therapy emerges as a viable and safe choice for individuals grappling with challenging traumatic medlinkspinal cord injuries/medlink, said experts (!--ref1--).

A California-based company has received approval for trying out the world's first stem therapy on patients affected with mild to severe Parkinson's disease.

Indian biotech sector poised for growth with cell and gene therapies revolutionising healthcare, positioning India as a global leader

CAR T-cell therapy works wonders for some cancer patients. For others, it is a death sentence. To make the revolutionary therapy work for more people, scientists must devise better ways to control it

Chimeric antigen receptor T-cell therapies have shown remarkable efficacy in leukemia and lymphoma patients who relapsed or were refractory to several prior treatments, but many challenges remain in the cancer cell therapy field. Strategies that may improve upon first-generation therapies were presented during the American Association for Cancer Research virtual meeting with encouraging early activity, […]

The submission of additional information, upon the request of the US regulator, has delayed the action…

Stem cell therapy aids a 26-year-old Duchenne Muscular Dystrophy (DMD) patient in UP to survive. Children suffering from DMD usually die of cardio-respiratory failure.

Michael Schumacher received stem cells to obtain an anti-inflammatory effect throughout his system, according to reports.

Online Resource

CAR T-cell therapy works wonders for some cancer patients. For others, it is a death sentence. To make the revolutionary therapy work for more people, scientists must devise better ways to control it